PREVISE CLOSES $3M SEED TO TACKLE EARLY CANCER DETECTION AND LAUNCHES COMPANY'S FIRST ESOPHAGEAL CANCER PROGNOSTIC TEST
/PRNewswire/ -- Previse, formerly known as Capsulomics, Inc., announced that the company has closed a $3M seed round and launched its first...